Everdime Technologies, Inc.
RGST · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $90 | $274 | $0 | $0 |
| % Growth | -66.9% | – | – | – |
| Cost of Goods Sold | $66 | $86 | $0 | $0 |
| Gross Profit | $24 | $188 | $0 | $0 |
| % Margin | 26.9% | 68.6% | – | – |
| R&D Expenses | $0 | $26 | $45 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $72 | $59 | $131 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$26 | $0 | $0 |
| Operating Expenses | $72 | $59 | $176 | $8 |
| Operating Income | -$47 | -$59 | -$176 | -$8 |
| % Margin | -52.2% | -21.4% | – | – |
| Other Income/Exp. Net | -$940 | -$1 | -$1,967 | -$0 |
| Pre-Tax Income | -$987 | -$60 | -$2,143 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$987 | -$60 | -$2,143 | -$8 |
| % Margin | -1,091.3% | -21.9% | – | – |
| EPS | -0.006 | -0 | -0.015 | -0 |
| % Growth | -1,500% | 97.4% | -7,450% | – |
| EPS Diluted | -0.006 | -0 | -0.015 | -0 |
| Weighted Avg Shares Out | 155,449 | 149,226 | 142,256 | 33,552 |
| Weighted Avg Shares Out Dil | 155,449 | 149,226 | 142,256 | 33,552 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $1 | $0 | $0 |
| Depreciation & Amortization | -$20 | $228 | $237 | $206 |
| EBITDA | -$67 | -$59 | -$176 | -$8 |
| % Margin | -74.5% | -21.4% | – | – |